A9513 |
Lutetium Lu 177 dotatat ther |
ADVANCED ACCELERATOR APPLICATIONS |
69488-0003-01 |
LUTATHERA |
1 MCI |
20 |
1 |
200 |
200 |
A9543 |
Y90 ibritumomab, rx |
SPECTRUM PHARMACEUTICALS |
68152-0103-03 |
ZEVALIN Y-90 |
UP TO 40 millicuries |
1 |
1 |
1 |
1 |
A9543 |
Y90 ibritumomab, rx |
ACROTECH BIOPHARMA |
72893-0007-04 |
ZEVALIN Y-90 |
UP TO 40 millicuries |
1 |
1 |
1 |
1 |
A9590 |
Iodine i-131 iobenguane 1mci |
PROGENICS PHARMACEUTICALS, INC. |
71258-0015-22 |
AZEDRA therapeutic |
1 mCi |
1 |
1 |
1 |
1 |
A9593 |
Gallium ga-68 psma-11 ucsf |
UCSF RADIOPHARMACEUTICAL FACILITY |
24275-0525-01 |
Gallium Ga 68 PSMA (UCSF) |
1 mCi |
11 |
1 |
1 |
1 |
A9594 |
Gallium ga-68 psma-11, ucla |
UCLA BIOMEDICAL CYCLOTRON |
76394-2642-03 |
Gallium Ga 68 PSMA (UCLA) |
1 mCi |
12 |
1 |
1 |
1 |
A9595 |
Piflu f-18, dia 1 millicurie |
PROGENICS PHARMACEUTICALS, INC |
71258-0022-00 |
Pylarify |
1 millicurie |
1 |
1 |
9 |
9 |
A9596 |
Gallium illuccix 1 millicure |
TELIX PHARMACEUTICALS, INC. |
74725-0100-25 |
ILLUCCIX |
1 mCi |
1 |
1 |
1 |
1 |
A9596 |
Gallium illuccix 1 millicure |
TELIX PHARMACEUTICALS, INC. |
74725-0100-64 |
ILLUCCIX |
1 mCi |
1 |
1 |
1 |
1 |
A9600 |
Sr89 strontium |
QBIOMED INC |
72928-0089-01 |
Strontium Chloride Sr 89 |
PER MILLICURIE |
4 |
1 |
1 |
4 |
A9601 |
Flortaucipir inj 1 millicuri |
ELI LILLY AND COMPANY |
00002-1220-01 |
Tauvid |
1 MCI |
1 |
1 |
1 |
1 |
A9601 |
Flortaucipir inj 1 millicuri |
Eli Lilly and Company |
00002-1220-48 |
Tauvid |
1 MCI |
100 |
1 |
1 |
1 |
A9601 |
Flortaucipir inj 1 millicuri |
Eli Lilly and Company |
00002-1220-50 |
Tauvid |
1 MCI |
50 |
1 |
1 |
1 |
A9602 |
Fluorodopa f-18 diag per mci |
THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH |
13267-0346-57 |
Fluorodopa F18 |
1 mCi |
1 |
1 |
1 |
1 |
A9604 |
Sm 153 lexidronam |
LANTHEUS MEDICAL IMAGING, INC. |
11994-0016-01 |
QUADRAMET |
up to 150 millicuries |
3 |
1 |
1 |
1 |
A9606 |
Radium Ra223 dichloride ther |
BAYER HEALTHCARE PHARMACEUTICALS INC. |
50419-0208-01 |
Xofigo |
1 mCi |
6 |
1 |
1 |
1 |
A9607 |
Lutetium lu 177 vipivotide |
ADVANCED ACCELERATOR APPLICATIONS USA, INC |
69488-0010-61 |
PLUVICTO |
1 mCi |
1 |
1 |
1 |
1 |
A9608 |
Flotufolastat f18 diag 1 mci |
Blue Earth Diagnostics |
69932-0002-01 |
Posluma |
1 mCi |
1 |
1 |
1 |
8 |
A9608 |
Flotufolastat f18 diag 1 mci |
Blue Earth Diagnostics |
69932-0002-50 |
Posluma |
1 MILLICURIE |
25 |
1 |
1 |
1 |
A9800 |
Gallium locametz 1 millicuri |
ADVANCED ACCELERATOR APPLICATIONS USA, INC |
69488-0017-61 |
LOCAMETZ |
1 mCi |
1 |
1 |
1 |
1 |
C9047 |
Injection, caplacizumab-yhdp |
GENZYME CORPORATION |
58468-0225-01 |
Cablivi |
1 MG |
1 |
1 |
11 |
11 |
C9088 |
Instill, bupivac and meloxic |
HERON THERAPEUTICS |
47426-0301-02 |
Zynrelef |
1 mg - 0.03 mg |
14 |
1 |
400 |
400 |
C9088 |
Instill, bupivac and meloxic |
HERON THERAPEUTICS |
47426-0303-01 |
Zynrelef |
1 mg - 0.03 mg |
7 |
1 |
200 |
200 |
C9089 |
Bupivacaine implant, 1 mg |
INNOCOLL PHARMACEUTICALS LIMITED |
51715-0100-04 |
Xaracoll |
1 mg |
1 |
12 |
100 |
1200 |
C9089 |
Bupivacaine implant, 1 mg |
INNOCOLL PHARMACEUTICALS LIMITED |
51715-0100-10 |
Xaracoll |
1 mg |
1 |
30 |
100 |
3000 |
C9101 |
Inj, oliceridine 0.1 mg |
TREVENA, INC. |
71308-0011-10 |
Olinvyk |
0.1 MG |
1 |
10 |
10 |
100 |
C9101 |
Inj, oliceridine 0.1 mg |
TREVENA, INC. |
71308-0021-10 |
Olinvyk |
0.1 MG |
2 |
10 |
20 |
200 |
C9101 |
Inj, oliceridine 0.1 mg |
TREVENA, INC. |
71308-0301-10 |
Olinvyk |
0.1 MG |
30 |
10 |
300 |
3000 |
C9144 |
Inj, bupivacaine (posimir) |
INNOCOLL PHARMACEUTICALS |
51715-0660-10 |
Posimir |
1 MG |
5 |
10 |
660 |
6600 |
C9145 |
Inj, aponvie, 1 mg |
HERON THERAPEUTICS, INC. |
47426-0401-10 |
APONVIE |
1 MG |
4.4 |
10 |
32 |
320 |
C9159 |
Inj, balfaxar, per i.u |
Octapharma USA Inc |
68982-0261-01 |
Balfaxar |
PER FACTOR IX IU |
1 |
1 |
1 |
1 |
C9159 |
Inj, balfaxar, per i.u |
Octapharma USA Inc |
68982-0261-02 |
Balfaxar |
PER FACTOR IX IU |
1 |
1 |
1 |
1 |
C9160 |
Inj daxibotulinumtoxinA-lanm |
Revance Therapeutics, Inc. |
72960-0112-01 |
Daxxify |
1 UNIT |
1 |
1 |
100 |
100 |
C9161 |
Inj, aflibercept hd, 1 mg |
Regeneron Pharmaceuticals, Inc |
61755-0050-01 |
Eylea HD |
1 MG |
0.07 |
1 |
8 |
8 |
C9161 |
Inj, aflibercept hd, 1 mg |
Regeneron Pharmaceuticals, Inc |
61755-0051-01 |
Eylea HD |
1 MG |
0.07 |
1 |
8 |
8 |
C9162 |
Inj, avacincaptad peg 0.1 mg |
IVERIC bio, Inc. |
82829-0002-01 |
Izervay |
0.1 MG |
0.1 |
1 |
20 |
20 |
C9163 |
Inj talquetamab-tgvs 0.25 mg |
Janssen Biotech |
57894-0469-01 |
Talvey |
0.25 MG |
1.5 |
1 |
12 |
12 |
C9163 |
Inj talquetamab-tgvs 0.25 mg |
Janssen Biotech |
57894-0470-01 |
Talvey |
0.25 MG |
1 |
1 |
160 |
160 |
C9164 |
Cantharidin top, applicator |
Verrica Pharmaceuticals |
71349-0070-01 |
Ycanth |
1 VIAL |
0.45 |
1 |
1 |
1 |
C9164 |
Cantharidin top, applicator |
Verrica Pharmaceuticals |
71349-0070-06 |
Ycanth |
1 VIAL |
0.45 |
6 |
1 |
6 |
C9164 |
Cantharidin top, applicator |
Verrica Pharmaceuticals |
71349-0070-12 |
Ycanth |
1 VIAL |
0.45 |
12 |
1 |
12 |
C9165 |
Inj, elranatamab-bcmm, 1 mg |
Pfizer |
00069-2522-02 |
Elrexfio |
1 MG |
1.1 |
1 |
44 |
44 |
C9165 |
Inj, elranatamab-bcmm, 1 mg |
Pfizer |
00069-4494-02 |
Elrexfio |
1 MG |
1.9 |
1 |
76 |
76 |
C9250 |
Artiss fibrin sealant |
BAXTER |
00338-9637-01 |
Artiss |
2 ML |
2 |
1 |
1 |
1 |
C9250 |
Artiss fibrin sealant |
BAXTER |
00338-9639-01 |
Artiss |
2 ML |
4 |
1 |
2 |
2 |
C9250 |
Artiss fibrin sealant |
BAXTER |
00338-9641-01 |
Artiss |
2 ML |
10 |
1 |
5 |
5 |
C9257 |
Bevacizumab injection |
GENENTECH, INC. |
50242-0060-01 |
Avastin |
0.25 MG |
4 |
1 |
400 |
400 |
C9257 |
Bevacizumab injection |
GENENTECH, INC. |
50242-0060-10 |
Avastin |
0.25 MG |
4 |
10 |
400 |
4000 |
C9257 |
Bevacizumab injection |
GENENTECH, INC. |
50242-0061-01 |
Avastin |
0.25 MG |
16 |
1 |
1600 |
1600 |
C9257 |
Bevacizumab injection |
GENENTECH, INC. |
50242-0061-10 |
Avastin |
0.25 MG |
16 |
10 |
1600 |
16000 |
C9290 |
Inj, bupivacaine liposome |
PACIRA PHARMACEUTICALS |
65250-0133-04 |
EXPAREL |
1 MG |
10 |
4 |
133 |
532 |
C9290 |
Inj, bupivacaine liposome |
PACIRA PHARMACEUTICALS |
65250-0133-09 |
EXPAREL |
1 MG |
10 |
10 |
133 |
1330 |
C9290 |
Inj, bupivacaine liposome |
PACIRA PHARMACEUTICALS |
65250-0266-04 |
EXPAREL |
1 MG |
20 |
4 |
266 |
1064 |
C9290 |
Inj, bupivacaine liposome |
PACIRA PHARMACEUTICALS |
65250-0266-09 |
EXPAREL |
1 MG |
20 |
10 |
266 |
2660 |
C9460 |
Injection, cangrelor |
CHIESI USA, INC. |
10122-0620-10 |
KENGREAL |
1 MG |
1 |
10 |
50 |
500 |
C9482 |
Sotalol hydrochloride IV |
ALTATHERA PHARMACEUTICALS |
69724-0112-10 |
Sotalol |
1MG |
10 |
1 |
150 |
150 |
C9488 |
Conivaptan HCL |
CUMBERLAND PHARMACEUTICALS |
66220-0160-10 |
VAPRISOL |
1 MG |
100 |
1 |
20 |
20 |
J0135 |
Adalimumab injection |
ABBVIE US, LLC |
00074-3799-02 |
Humira |
20 MG |
0.8 |
2 |
2 |
4 |
J0135 |
Adalimumab injection |
ABBVIE US, LLC |
00074-4339-02 |
Humira |
20 MG |
0.8 |
2 |
2 |
4 |
J0135 |
Adalimumab injection |
ABBVIE US, LLC |
00074-4339-06 |
Humira |
20 MG |
0.8 |
6 |
2 |
12 |
J0135 |
Adalimumab injection |
ABBVIE US, LLC |
00074-4339-07 |
Humira |
20 MG |
0.8 |
4 |
2 |
8 |
J0184 |
Inj, amisulpride, 1 mg |
ACACIA PHARMA, INC. |
71390-0125-20 |
BARHEMSYS |
1 MG |
2 |
10 |
5 |
50 |
J0184 |
Inj, amisulpride, 1 mg |
ACACIA PHARMA, INC. |
71390-0125-50 |
BARHEMSYS |
1 MG |
4 |
10 |
10 |
100 |
J0208 |
Inj sodium thiosulfate 100mg |
FENNEC PHARMACEUTICALS INC. |
73077-0010-01 |
Sodium Thiosulfate |
100 MG |
100 |
1 |
125 |
125 |
J0217 |
Inj velmanase alfa-tycv 1 mg |
Chiesi USA, |
10122-0180-02 |
Lamzede |
1 MG |
1 |
1 |
10 |
10 |
J0217 |
Inj velmanase alfa-tycv 1 mg |
Chiesi USA, |
10122-0180-05 |
Lamzede |
1 MG |
1 |
5 |
10 |
50 |
J0217 |
Inj velmanase alfa-tycv 1 mg |
Chiesi USA, |
10122-0180-10 |
Lamzede |
1 MG |
1 |
1 |
10 |
10 |
J0287 |
Amphotericin b lipid complex |
LEADIANT BIOSCIENCES, INC. |
57665-0101-41 |
Abelcet |
10 MG |
20 |
1 |
10 |
10 |
J0349 |
Inj, rezafungin, 1 mg |
Melinta Therapeutics, LLC |
70842-0240-01 |
REZZAYO |
1 MG |
1 |
1 |
200 |
200 |
J0391 |
Inj, artesunate, 1mg |
AMIVAS (US), LLC |
73607-0011-11 |
Artesunate |
1 MG |
1 |
2 |
110 |
220 |
J0470 |
Dimecaprol injection |
AKORN |
17478-0526-03 |
Bal In Oil |
100 MG |
3 |
10 |
3 |
30 |
J0570 |
Buprenorphine implant 74.2mg |
TITAN PHARMACEUTICALS |
52440-0100-14 |
PROBUPHINE SYSTEM KIT |
74.2 MG |
1 |
4 |
1 |
4 |
J0576 |
Inj buprenorph (brixadi) 1mg |
BRAEBURN INC. |
58284-0228-01 |
Brixadi (monthly dosing) |
1 MG |
0.36 |
1 |
128 |
128 |
J0576 |
Inj buprenorph (brixadi) 1mg |
BRAEBURN INC. |
58284-0264-01 |
Brixadi (monthly dosing) |
1 MG |
0.18 |
1 |
64 |
64 |
J0576 |
Inj buprenorph (brixadi) 1mg |
BRAEBURN INC. |
58284-0296-01 |
Brixadi (monthly dosing) |
1 MG |
0.27 |
1 |
96 |
96 |
J0576 |
Inj buprenorph (brixadi) 1mg |
BRAEBURN INC. |
58284-0208-01 |
Brixadi (weekly dosing) |
1 MG |
0.16 |
1 |
8 |
8 |
J0576 |
Inj buprenorph (brixadi) 1mg |
BRAEBURN INC. |
58284-0216-01 |
Brixadi (weekly dosing) |
1 MG |
0.32 |
1 |
16 |
16 |
J0576 |
Inj buprenorph (brixadi) 1mg |
BRAEBURN INC. |
58284-0224-01 |
Brixadi (weekly dosing) |
1 MG |
0.48 |
1 |
24 |
24 |
J0576 |
Inj buprenorph (brixadi) 1mg |
BRAEBURN INC. |
58284-0232-01 |
Brixadi (weekly dosing) |
1 MG |
0.64 |
1 |
32 |
32 |
J0600 |
Edetate calcium disodium inj |
RISING PHARMACEUTICALS |
64980-0588-51 |
Calcium Disodium Edetate |
1000 MG |
5 |
5 |
1 |
5 |
J0600 |
Edetate calcium disodium inj |
MEDICIS PHARMACEUTICALS |
99207-0240-05 |
Calcium Disodium Versenate |
1000 MG |
5 |
5 |
1 |
5 |
J0606 |
Inj, etelcalcetide, 0.1 mg |
AMGEN USA, INC. |
55513-0740-10 |
Parsabiv |
0.1 MG |
0.5 |
10 |
25 |
250 |
J0606 |
Inj, etelcalcetide, 0.1 mg |
AMGEN USA, INC. |
55513-0741-10 |
Parsabiv |
0.1 MG |
1 |
10 |
50 |
500 |
J0606 |
Inj, etelcalcetide, 0.1 mg |
AMGEN USA, INC. |
55513-0742-10 |
Parsabiv |
0.1 MG |
2 |
10 |
100 |
1000 |
J0691 |
Inj lefamulin 1 mg |
NABRIVA THERAPEUTICS US, INC |
72000-0120-06 |
Xenleta |
1 MG |
150 |
6 |
150 |
900 |
J0716 |
Centruroides immune f(ab) |
RARE DISEASE THERAPEUTICS, INC. |
66621-0150-02 |
ANASCORP |
UP TO 120MG |
1 |
1 |
1 |
1 |
J0884 |
Argatroban esrd dialysis 1mg |
NOVARTIS PHARMACEUTICALS CORPORATION |
00078-0930-61 |
Argatroban |
1 MG |
2.5 |
1 |
250 |
250 |
J0884 |
Argatroban esrd dialysis 1mg |
HIKMA PHARMACEUTICALS USA INC. |
00143-9288-01 |
Argatroban |
1 MG |
2.5 |
1 |
250 |
250 |
J0884 |
Argatroban esrd dialysis 1mg |
HIKMA PHARMACEUTICALS USA INC. |
00143-9377-01 |
Argatroban |
1 MG |
50 |
1 |
50 |
50 |
J0884 |
Argatroban esrd dialysis 1mg |
HIKMA PHARMACEUTICALS USA INC. |
00143-9559-01 |
ARGATROBAN |
1 MG |
50 |
1 |
50 |
50 |
J0884 |
Argatroban esrd dialysis 1mg |
HIKMA PHARMACEUTICALS USA INC. |
00143-9674-01 |
Argatroban |
1 MG |
2.5 |
1 |
250 |
250 |
J0884 |
Argatroban esrd dialysis 1mg |
PFIZER INC. |
00409-1140-01 |
Argatroban |
1 MG |
2.5 |
1 |
250 |
250 |
J0884 |
Argatroban esrd dialysis 1mg |
SAGENT PHARMACEUTICALS INC |
25021-0414-50 |
ARGATROBAN |
1 MG |
50 |
1 |
50 |
50 |
J0884 |
Argatroban esrd dialysis 1mg |
PAR PHARMACEUTICAL, INC |
42023-0182-01 |
Argatroban |
1 MG |
2.5 |
1 |
250 |
250 |
J0884 |
Argatroban esrd dialysis 1mg |
PAR PHARMACEUTICAL |
42023-0182-89 |
ARGATROBAN |
1 MG |
2.5 |
1 |
250 |
250 |
J0884 |
Argatroban esrd dialysis 1mg |
FRESENIUS KABI |
63323-0526-03 |
Argatroban |
1 MG |
2.5 |
1 |
250 |
250 |
J0884 |
Argatroban esrd dialysis 1mg |
FRESENIUS KABI |
65219-0429-50 |
ARGATROBAN |
1 MG |
50 |
1 |
50 |
50 |
J0884 |
Argatroban esrd dialysis 1mg |
MYLAN INSTITUTIONAL LLC |
67457-0212-02 |
Argatroban |
1 MG |
2.5 |
1 |
250 |
250 |
J0899 |
Argatroban dialysis, auromed |
AUROMEDICS PHARMA LLC |
55150-0241-01 |
Argatroban |
1 MG |
50 |
1 |
50 |
50 |
J0899 |
Argatroban dialysis, auromed |
AUROMEDICS PHARMA LLC |
55150-0241-10 |
ARGATROBAN |
1 MG |
50 |
10 |
50 |
500 |
J1096 |
Dexametha opth insert 0.1 mg |
OCULAR THERAPEUTIX |
70382-0204-01 |
Dextenza |
0.1 MG |
1 |
1 |
4 |
4 |
J1096 |
Dexametha opth insert 0.1 mg |
OCULAR THERAPEUTIX |
70382-0204-10 |
Dextenza |
0.1 MG |
1 |
10 |
4 |
40 |
J1097 |
Phenylep ketorolac opth soln |
OMEROS CORPORATION |
62225-0600-04 |
Omidria (phenylephrine 1% + ketorolac 0.3% irrigation) |
1 ML |
4 |
4 |
4 |
16 |
J1105 |
Dexmedetomidine film, 1 mcg |
BIOXCEL THERAPEUTICS, INC. |
81092-1120-01 |
IGALMI |
1 MCG |
10 |
1 |
1200 |
1200 |
J1105 |
Dexmedetomidine film, 1 mcg |
BIOXCEL THERAPEUTICS, INC. |
81092-1180-01 |
IGALMI |
1 MCG |
10 |
1 |
1800 |
1800 |
J1327 |
Eptifibatide injection |
BAXTER |
00338-9558-10 |
Eptifibatide |
5 MG |
100 |
12 |
15 |
180 |
J1327 |
Eptifibatide injection |
SAGENT PHARMACEUTICALS INC |
25021-0408-51 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
SAGENT PHARMACEUTICALS INC |
25021-0409-10 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
AUROMEDICS PHARMA LLC |
55150-0218-99 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
AUROMEDICS PHARMA LLC |
55150-0219-10 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
AUROMEDICS PHARMA LLC |
55150-0220-99 |
Eptifibatide |
5 MG |
100 |
1 |
40 |
40 |
J1327 |
Eptifibatide injection |
MYLAN INSTITUTIONAL LLC |
67457-0629-10 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
MYLAN INSTITUTIONAL LLC |
67457-0630-10 |
Eptifibatide |
5 MG |
100 |
1 |
40 |
40 |
J1327 |
Eptifibatide injection |
MYLAN INSTITUTIONAL LLC |
67457-0631-10 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
SLATE RUN |
70436-0026-80 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
SLATE RUN |
70436-0027-80 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
SLATE RUN |
70436-0162-80 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
SLATE RUN |
70436-0163-80 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
ATHENEX PHARMACEUTICAL |
70860-0303-10 |
EPTIFIBATIDE |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
ATHENEX |
70860-0305-51 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
MYLAN INSTITUTIONAL LLC |
72078-0025-10 |
Eptifibatide |
5 MG |
10 |
1 |
4 |
4 |
J1327 |
Eptifibatide injection |
MYLAN INSTITUTIONAL LLC |
72078-0026-10 |
Eptifibatide |
5 MG |
100 |
1 |
15 |
15 |
J1327 |
Eptifibatide injection |
MYLAN INSTITUTIONAL LLC |
72078-0027-10 |
Eptifibatide |
5 MG |
100 |
1 |
40 |
40 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0100-10 |
Hemgenix |
Per Therapeutic Dose |
10 |
10 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0110-11 |
Hemgenix |
Per Therapeutic Dose |
10 |
11 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0120-12 |
Hemgenix |
Per Therapeutic Dose |
10 |
12 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0130-13 |
Hemgenix |
Per Therapeutic Dose |
10 |
13 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0140-14 |
Hemgenix |
Per Therapeutic Dose |
10 |
14 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0150-15 |
Hemgenix |
Per Therapeutic Dose |
10 |
15 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0160-16 |
Hemgenix |
Per Therapeutic Dose |
10 |
16 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0170-17 |
Hemgenix |
Per Therapeutic Dose |
10 |
17 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0180-18 |
Hemgenix |
Per Therapeutic Dose |
10 |
18 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0190-19 |
Hemgenix |
Per Therapeutic Dose |
10 |
19 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0200-20 |
Hemgenix |
Per Therapeutic Dose |
10 |
20 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0210-21 |
Hemgenix |
Per Therapeutic Dose |
10 |
21 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0220-22 |
Hemgenix |
Per Therapeutic Dose |
10 |
22 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0230-23 |
Hemgenix |
Per Therapeutic Dose |
10 |
23 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0240-24 |
Hemgenix |
Per Therapeutic Dose |
10 |
24 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0250-25 |
Hemgenix |
Per Therapeutic Dose |
10 |
25 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0260-26 |
Hemgenix |
Per Therapeutic Dose |
10 |
26 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0270-27 |
Hemgenix |
Per Therapeutic Dose |
10 |
27 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0280-28 |
Hemgenix |
Per Therapeutic Dose |
10 |
28 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0290-29 |
Hemgenix |
Per Therapeutic Dose |
10 |
29 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0300-30 |
Hemgenix |
Per Therapeutic Dose |
10 |
30 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0310-31 |
Hemgenix |
Per Therapeutic Dose |
10 |
31 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0320-32 |
Hemgenix |
Per Therapeutic Dose |
10 |
32 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0330-33 |
Hemgenix |
Per Therapeutic Dose |
10 |
33 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0340-34 |
Hemgenix |
Per Therapeutic Dose |
10 |
34 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0350-35 |
Hemgenix |
Per Therapeutic Dose |
10 |
35 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0360-36 |
Hemgenix |
Per Therapeutic Dose |
10 |
36 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0370-37 |
Hemgenix |
Per Therapeutic Dose |
10 |
37 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0380-38 |
Hemgenix |
Per Therapeutic Dose |
10 |
38 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0390-39 |
Hemgenix |
Per Therapeutic Dose |
10 |
39 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0400-40 |
Hemgenix |
Per Therapeutic Dose |
10 |
40 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0410-41 |
Hemgenix |
Per Therapeutic Dose |
10 |
41 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0420-42 |
Hemgenix |
Per Therapeutic Dose |
10 |
42 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0430-43 |
Hemgenix |
Per Therapeutic Dose |
10 |
43 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0440-44 |
Hemgenix |
Per Therapeutic Dose |
10 |
44 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0450-45 |
Hemgenix |
Per Therapeutic Dose |
10 |
45 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0460-46 |
Hemgenix |
Per Therapeutic Dose |
10 |
46 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0470-47 |
Hemgenix |
Per Therapeutic Dose |
10 |
47 |
1 |
1 |
J1411 |
Inj, hemgenix, per tx dose |
CSL Behring |
00053-0480-48 |
Hemgenix |
Per Therapeutic Dose |
10 |
48 |
1 |
1 |
J1412 |
Inj roctavian ml 2x10^13vc g |
BioMarin Pharmaceutical Inc. |
68135-0927-48 |
Roctavian |
1 ML |
8 |
1 |
8 |
8 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0501-10 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
10 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0502-11 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
11 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0503-12 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
12 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0504-13 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
13 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0505-14 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
14 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0506-15 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
15 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0507-16 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
16 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0508-17 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
17 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0509-18 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
18 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0510-19 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
19 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0511-20 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
20 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0512-21 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
21 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0513-22 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
22 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0514-23 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
23 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0515-24 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
24 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0516-25 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
25 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0517-26 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
26 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0518-27 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
27 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0519-28 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
28 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0520-29 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
29 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0521-30 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
30 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0522-31 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
31 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0523-32 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
32 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0524-33 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
33 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0525-34 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
34 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0526-35 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
35 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0527-36 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
36 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0528-37 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
37 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0529-38 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
38 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0530-39 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
39 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0531-40 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
40 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0532-41 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
41 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0533-42 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
42 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0534-43 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
43 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0535-44 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
44 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0536-45 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
45 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0537-46 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
46 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0538-47 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
47 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0539-48 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
48 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0540-49 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
49 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0541-50 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
50 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0542-51 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
51 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0543-52 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
52 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0544-53 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
53 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0545-54 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
54 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0546-55 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
55 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0547-56 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
56 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0548-57 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
57 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0549-58 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
58 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0550-59 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
59 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0551-60 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
60 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0552-61 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
61 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0553-62 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
62 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0554-63 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
63 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0555-64 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
64 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0556-65 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
65 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0557-66 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
66 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0558-67 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
67 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0559-68 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
68 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0560-69 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
69 |
1 |
1 |
J1413 |
Inj delandistrogene mox rokl |
Sarepta Therapeutics |
60923-0561-70 |
Elevidys |
PER THERAPEUTIC DOSE |
1 |
70 |
1 |
1 |
J1426 |
Injection, casimersen, 10 mg |
SAREPTA |
60923-0227-02 |
Amondys 45 |
10 MG |
2 |
1 |
10 |
10 |
J1427 |
Inj. viltolarsen |
NS PHARMA INC |
73292-0011-01 |
Viltepso |
10 MG |
5 |
1 |
25 |
25 |
J1429 |
Inj golodirsen 10 mg |
SAREPTA |
60923-0465-02 |
Vyondys 53 |
10 MG |
2 |
1 |
10 |
10 |
J1438 |
Etanercept injection |
AMGEN USA, INC. |
58406-0425-34 |
Enbrel |
25 MG |
1 |
4 |
1 |
4 |
J1438 |
Etanercept injection |
AMGEN USA, INC. |
58406-0445-04 |
Enbrel |
25 MG |
1 |
4 |
2 |
8 |
J1438 |
Etanercept injection |
AMGEN USA, INC. |
58406-0455-04 |
Enbrel |
25 MG |
0.5 |
4 |
1 |
4 |
J1438 |
Etanercept injection |
AMGEN USA, INC. |
58406-0435-04 |
Enbrel (Etanercept) |
25 MG |
1 |
4 |
2 |
8 |
J1451 |
Fomepizole, 15 mg |
AMERICAN REGENT |
00517-0710-01 |
FOMEPIZOLE |
15 MG |
1.5 |
1 |
100 |
100 |
J1451 |
Fomepizole, 15 mg |
MYLAN INSTITUTIONAL LLC |
67457-0211-02 |
FOMEPIZOLE |
15 MG |
1.5 |
1 |
100 |
100 |
J1451 |
Fomepizole, 15 mg |
ZYDUS PHARMACEUTICALS |
70710-1478-01 |
Fomepizole |
15 MG |
1.5 |
1 |
100 |
100 |
J1455 |
Foscarnet sodium injection |
SAGENT PHARMACEUTICALS INC |
25021-0189-84 |
FOSCARNET SODIUM |
1000 MG |
250 |
10 |
6 |
60 |
J1455 |
Foscarnet sodium injection |
BAXTER HEALTHCARE CORP |
43066-0089-10 |
FOSCARNET SODIUM |
1000 MG |
250 |
10 |
6 |
60 |
J1455 |
Foscarnet sodium injection |
FRESENIUS KABI |
63323-0875-50 |
Foscarnet Sodium |
1000 MG |
250 |
1 |
6 |
6 |
J1572 |
Flebogamma injection |
GRIFOLS USA, LLC |
61953-0005-01 |
FLEBOGAMMA 10% DIF |
500 MG |
50 |
1 |
10 |
10 |
J1572 |
Flebogamma injection |
GRIFOLS USA, LLC |
61953-0005-02 |
FLEBOGAMMA 10% DIF |
500 MG |
100 |
1 |
20 |
20 |
J1572 |
Flebogamma injection |
GRIFOLS USA, LLC |
61953-0005-03 |
FLEBOGAMMA 10% DIF |
500 MG |
200 |
1 |
40 |
40 |
J1572 |
Flebogamma injection |
GRIFOLS USA, LLC |
61953-0004-02 |
Flebogamma DIF |
500 MG |
50 |
1 |
5 |
5 |
J1572 |
Flebogamma injection |
GRIFOLS USA, LLC |
61953-0004-03 |
Flebogamma DIF |
500 MG |
100 |
1 |
10 |
10 |
J1572 |
Flebogamma injection |
GRIFOLS USA, LLC |
61953-0004-04 |
Flebogamma DIF |
500 MG |
200 |
1 |
20 |
20 |
J1572 |
Flebogamma injection |
GRIFOLS USA, LLC |
61953-0004-05 |
Flebogamma DIF |
500 MG |
400 |
1 |
40 |
40 |
J1573 |
Hepagam b intravenous, inj |
SAOL THERAPEUTICS |
70257-0051-51 |
Hepagam B |
0.5 ML |
5 |
1 |
10 |
10 |
J1573 |
Hepagam b intravenous, inj |
SAOL THERAPEUTICS |
70257-0052-51 |
HEPAGAM B |
0.5 ML |
1 |
1 |
2 |
2 |
J1573 |
Hepagam b intravenous, inj |
SAOL THERAPEUTICS |
70257-0053-51 |
Hepagam B |
0.5 ML |
1 |
1 |
2 |
2 |
J1573 |
Hepagam b intravenous, inj |
SAOL THERAPEUTICS |
70257-0054-51 |
Hepagam B |
0.5 ML |
5 |
1 |
10 |
10 |
J1595 |
Injection glatiramer acetate |
TEVA NEUROSCIENCE, INC. |
68546-0317-30 |
Copaxone |
20 MG |
1 |
30 |
1 |
30 |
J1595 |
Injection glatiramer acetate |
TEVA NEUROSCIENCE, INC. |
68546-0325-12 |
Copaxone |
20 MG |
1 |
12 |
2 |
24 |
J1628 |
Inj., guselkumab, 1 mg |
JANSSEN BIOTECH, INC. |
57894-0640-01 |
Tremfya |
1 MG |
1 |
1 |
100 |
100 |
J1628 |
Inj., guselkumab, 1 mg |
JANSSEN BIOTECH, INC. |
57894-0640-11 |
Tremfya |
1 MG |
1 |
1 |
100 |
100 |
J1632 |
Inj, brexanolone |
SAGE THERAPEUTICS |
72152-0547-20 |
Zulresso |
1 MG |
20 |
1 |
100 |
100 |
J1726 |
Inj, Makena |
AMERICAN REGENT |
00517-1791-01 |
Hydroxyprogesterone Caproate |
10 MG |
1 |
1 |
25 |
25 |
J1726 |
Inj, Makena |
AUROMEDICS PHARMA LLC |
55150-0309-01 |
Hydroxyprogesterone Caproate |
10 MG |
1 |
1 |
25 |
25 |
J1726 |
Inj, Makena |
AUROMEDICS PHARMA LLC |
55150-0310-01 |
Hydroxyprogesterone Caproate |
10 MG |
5 |
1 |
125 |
125 |
J1726 |
Inj, Makena |
MYLAN INSTITUTIONAL LLC |
67457-0886-05 |
Hydroxyprogesterone Caproate |
10 MG |
1 |
1 |
125 |
125 |
J1726 |
Inj, Makena |
MYLAN INSTITUTIONAL LLC |
67457-0967-01 |
Hydroxyprogesterone Caproate |
10 MG |
1 |
1 |
25 |
25 |
J1726 |
Inj, Makena |
AMNEAL PHARMACEUTICALS, LLC |
69238-1797-01 |
Hydroxyprogesterone Caproate |
10 MG |
1 |
1 |
25 |
25 |
J1726 |
Inj, Makena |
SLAYBACK PHARMA |
71225-0104-01 |
Hydroxyprogesterone Caproate |
10 MG |
5 |
1 |
125 |
125 |
J1726 |
Inj, Makena |
SLAYBACK PHARMA |
71225-0105-01 |
Hydroxyprogesterone Caproate |
10 MG |
1 |
1 |
25 |
25 |
J1726 |
Inj, Makena |
AMERICAN REGENT |
00517-1767-01 |
MAKENA |
10 MG |
1 |
1 |
25 |
25 |
J1726 |
Inj, Makena |
AMAG PHARMACEUTICALS, INC. |
64011-0301-03 |
Makena Auto Injector |
10 MG |
1.1 |
1 |
27.5 |
27.5 |
J1742 |
Ibutilide fumarate injection |
MYLAN INSTITUTIONAL LLC |
67457-0366-10 |
IBUTILIDE FUMARATE |
1 MG |
10 |
1 |
1 |
1 |
J1742 |
Ibutilide fumarate injection |
PFIZER INC. |
00009-3794-01 |
Corvert |
1 MG |
10 |
1 |
1 |
1 |
J1742 |
Ibutilide fumarate injection |
PFIZER INC. |
00009-3794-22 |
Corvert |
1 MG |
10 |
1 |
1 |
1 |
J1744 |
Icatibant injection |
LEUCADIA PHARMACEUTICALS |
24201-0207-01 |
ICATIBANT |
1 MG |
3 |
1 |
30 |
30 |
J1744 |
Icatibant injection |
TAKEDA PHARMACEUTICALS AMERICA, INC. |
54092-0702-02 |
ICATIBANT |
1 MG |
3 |
1 |
30 |
30 |
J1744 |
Icatibant injection |
TAKEDA PHARMACEUTICALS AMERICA, INC. |
54092-0702-03 |
ICATIBANT |
1 MG |
3 |
3 |
30 |
90 |
J1744 |
Icatibant injection |
FRESENIUS KABI |
63323-0574-86 |
ICATIBANT |
1 MG |
3 |
1 |
30 |
30 |
J1744 |
Icatibant injection |
FRESENIUS KABI |
63323-0574-93 |
ICATIBANT |
1 MG |
3 |
3 |
30 |
90 |
J1744 |
Icatibant injection |
CIPLA USA INC. |
69097-0664-34 |
ICATIBANT |
1 MG |
3 |
1 |
30 |
30 |
J1744 |
Icatibant injection |
CIPLA USA INC. |
69097-0664-68 |
ICATIBANT |
1 MG |
3 |
3 |
30 |
90 |
J1833 |
Inj, isavuconazonium sulfate |
ASTELLAS |
00469-0420-01 |
CRESEMBA |
1 MG |
1 |
1 |
372 |
372 |
J1833 |
Inj, isavuconazonium sulfate |
ASTELLAS PHARMA US INC. |
00469-0420-99 |
CRESEMBA injection |
1mg (as sulfate) |
1 |
10 |
372 |
3720 |
J2186 |
Inj., meropenem, vaborbactam |
MELINTA THERAPEUTICS, INC. |
70842-0120-06 |
Vabomere (meropenem-vaborbactam) |
(10 MG/10MG) 20 MG |
1 |
6 |
100 |
600 |
J2212 |
Methylnaltrexone injection |
SALIX PHARMACEUTICALS |
65649-0551-02 |
RELISTOR |
0.1 MG |
0.6 |
1 |
120 |
120 |
J2212 |
Methylnaltrexone injection |
SALIX PHARMACEUTICALS |
65649-0551-03 |
RELISTOR |
0.1 MG |
0.6 |
7 |
120 |
840 |
J2212 |
Methylnaltrexone injection |
SALIX PHARMACEUTICALS |
65649-0551-07 |
RELISTOR |
0.1 MG |
0.6 |
1 |
120 |
120 |
J2212 |
Methylnaltrexone injection |
SALIX PHARMACEUTICALS |
65649-0552-04 |
RELISTOR |
0.1 MG |
0.4 |
7 |
80 |
560 |
J2265 |
Minocycline hydrochloride |
MELINTA THERAPEUTICS, INC. |
70842-0160-10 |
MINOCIN |
1 MG |
1 |
10 |
100 |
1000 |
J2326 |
Injection, nusinersen |
BIOGEN |
64406-0058-01 |
Spinraza |
0.1 MG |
5 |
1 |
120 |
120 |
J2403 |
Chloroprocaine opht gel, 1mg |
Harrow Eye, Llc. |
82667-0300-01 |
IHEEZO |
1 MG |
1 |
1 |
800 |
800 |
J2403 |
Chloroprocaine opht gel, 1mg |
Harrow Eye, Llc. |
82667-0300-10 |
IHEEZO |
1 MG |
1 |
10 |
800 |
8000 |
J2425 |
Palifermin injection |
SOBI |
66658-0112-03 |
Kepivance |
50 MCG |
1 |
3 |
125 |
375 |
J2425 |
Palifermin injection |
SOBI |
66658-0112-06 |
Kepivance/Palifermin |
50 MCG |
1 |
6 |
125 |
750 |
J2502 |
Inj, pasireotide long acting |
NOVARTIS PHARMACEUTICALS CORPORATION |
00078-0641-81 |
Signifor LAR |
1 MG |
1 |
1 |
20 |
20 |
J2502 |
Inj, pasireotide long acting |
NOVARTIS PHARMACEUTICALS CORPORATION |
00078-0642-81 |
Signifor LAR |
1 MG |
1 |
1 |
40 |
40 |
J2502 |
Inj, pasireotide long acting |
NOVARTIS PHARMACEUTICALS CORPORATION |
00078-0643-81 |
Signifor LAR |
1 MG |
1 |
1 |
60 |
60 |
J2502 |
Inj, pasireotide long acting |
NOVARTIS PHARMACEUTICALS CORPORATION |
00078-0741-81 |
Signifor LAR |
1 MG |
1 |
1 |
30 |
30 |
J2502 |
Inj, pasireotide long acting |
NOVARTIS PHARMACEUTICALS CORPORATION |
00078-0748-81 |
Signifor LAR |
1 MG |
1 |
1 |
10 |
10 |
J2502 |
Inj, pasireotide long acting |
RECORDATI RARE DISEASES |
55292-0139-01 |
Signifor Lar |
1 MG |
1 |
1 |
10 |
10 |
J2502 |
Inj, pasireotide long acting |
RECORDATI RARE DISEASES |
55292-0140-01 |
Signifor Lar |
1 MG |
1 |
1 |
20 |
20 |
J2502 |
Inj, pasireotide long acting |
RECORDATI RARE DISEASES |
55292-0141-01 |
Signifor Lar |
1 MG |
1 |
1 |
30 |
30 |
J2502 |
Inj, pasireotide long acting |
RECORDATI RARE DISEASES |
55292-0142-01 |
Signifor Lar |
1 MG |
1 |
1 |
40 |
40 |
J2502 |
Inj, pasireotide long acting |
RECORDATI RARE DISEASES |
55292-0143-01 |
Signifor Lar |
1 MG |
1 |
1 |
60 |
60 |
J2508 |
Pegunigalsidase alfa-iwxj |
Chiesi USA |
10122-0160-02 |
Elfabrio |
1 MG |
10 |
1 |
20 |
20 |
J2508 |
Pegunigalsidase alfa-iwxj |
Chiesi USA |
10122-0160-05 |
Elfabrio |
1 MG |
10 |
5 |
20 |
100 |
J2508 |
Pegunigalsidase alfa-iwxj |
Chiesi USA |
10122-0160-10 |
Elfabrio |
1 MG |
10 |
10 |
20 |
200 |
J2510 |
Penicillin g procaine inj |
PFIZER INC. |
60793-0130-10 |
Penicillin G Procaine |
up to 600000 UNITS |
1 |
10 |
1 |
10 |
J2510 |
Penicillin g procaine inj |
PFIZER INC. |
60793-0131-10 |
Penicillin G Procaine |
up to 600000 UNITS |
2 |
10 |
2 |
20 |
J2547 |
Injection, peramivir |
BIOCRYST |
72769-0181-03 |
Rapivab |
1 MG |
20 |
3 |
200 |
600 |
J2770 |
Quinupristin/dalfopristin |
PFIZER INC. |
61570-0260-10 |
Synercid |
500 MG |
1 |
10 |
1 |
10 |
J2840 |
Injection, sebelipase alfa |
ALEXION PHARMACEUTICALS |
25682-0007-01 |
Kanuma |
1 MG |
10 |
1 |
20 |
20 |
J2850 |
Inj secretin synthetic human |
CHIRHOCLIN, INC. |
67066-0005-01 |
CHIRHOSTIM |
1 MCG |
1 |
1 |
16 |
16 |
J2993 |
Reteplase injection |
CHIESI USA, INC. |
10122-0141-02 |
RETAVASE KIT |
18.1 MG |
1 |
2 |
1 |
2 |
J2998 |
Inj plasminogen tvmh 1mg |
Prometic |
70573-0099-02 |
Ryplazim |
1 mg |
1 |
1 |
68.8 |
68.8 |
J3031 |
Inj., fremanezumab-vfrm 1 mg |
NUPATHE INC |
51759-0202-10 |
Ajovy |
1 MG |
1.5 |
1 |
225 |
225 |
J3031 |
Inj., fremanezumab-vfrm 1 mg |
NUPATHE INC |
51759-0202-22 |
Ajovy |
1 MG |
1.5 |
3 |
225 |
675 |
J3031 |
Inj., fremanezumab-vfrm 1 mg |
NUPATHE INC |
51759-0204-10 |
Ajovy |
1 MG |
1.5 |
1 |
225 |
225 |
J3244 |
Inj. tigecycline (accord) |
ACCORD HEALTHCARE INC. |
16729-0364-68 |
Tigecycline |
1 MG |
1 |
10 |
50 |
500 |
J3316 |
Inj., triptorelin xr 3.75 mg |
ARBOR PHARMACEUTICAL |
24338-0150-20 |
Triptodur |
3.75 MG |
1 |
1 |
6 |
6 |
J3398 |
Inj luxturna 1 billion vec g |
SPARK THERAPEUTICS, INC. |
71394-0415-01 |
LUXTURNA |
1 billion vector genomes |
0.5 |
1 |
150 |
150 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0122-03 |
Zolgensma 1x5.5 mL vial and 2x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
22.1 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0125-04 |
Zolgensma 1x5.5 mL vial and 3x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
30.4 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0128-05 |
Zolgensma 1x5.5 mL vial and 4x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
38.7 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0131-06 |
Zolgensma 1x5.5 mL vial and 5x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
47 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0134-07 |
Zolgensma 1x5.5 mL vial and 6x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
55.3 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0137-08 |
Zolgensma 1x5.5 mL vial and 7x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
63.6 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0140-09 |
Zolgensma 1x5.5 mL vial and 9x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
71.9 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0121-03 |
Zolgensma 2x5.5 mL vial and 1x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
19.3 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0124-04 |
Zolgensma 2x5.5 mL vial and 2x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
27.6 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0127-05 |
Zolgensma 2x5.5 mL vial and 3x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
35.9 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0130-06 |
Zolgensma 2x5.5 mL vial and 4x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
44.2 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0133-07 |
Zolgensma 2x5.5 mL vial and 5x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
52.5 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0136-08 |
Zolgensma 2x5.5 mL vial and 6x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
60.8 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0139-09 |
Zolgensma 2x5.5 mL vial and 7x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
69.1 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0120-02 |
Zolgensma 2x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
16.6 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0123-03 |
Zolgensma 3x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
24.9 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0126-04 |
Zolgensma 4x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
33.2 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0129-05 |
Zolgensma 5x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
41.5 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0132-06 |
Zolgensma 6x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
49.8 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0135-07 |
Zolgensma 7x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
58.1 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0138-08 |
Zolgensma 8x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
66.4 |
1 |
1 |
1 |
J3399 |
Inj onase abepar-xioi treat |
AVEXIS |
71894-0141-09 |
Zolgensma 9x8.3 mL vial Kit |
per tx dose (up to 5 x10^15 vg?) |
74.7 |
1 |
1 |
1 |
J3401 |
Vyjuvek 5x10^9pfu/ml, 0.1 ml |
Krystal Biotech |
82194-0510-02 |
Vyjuvek |
0.1 ML |
1 |
1 |
10 |
10 |
J7168 |
Prothrombin complex kcentra |
CSL BEHRING LLC |
63833-0386-02 |
Kcentra |
1 IU |
1 |
1 |
1 |
1 |
J7168 |
Prothrombin complex kcentra |
CSL BEHRING LLC |
63833-0387-02 |
Kcentra |
1 IU |
1 |
1 |
1 |
1 |
J7169 |
Inj andexxa, 10 mg |
ASTRAZENECA PHARMACEUTICALS, LP |
00310-3200-04 |
Andexxa |
10 MG |
1 |
4 |
20 |
80 |
J7169 |
Inj andexxa, 10 mg |
ASTRAZENECA PHARMACEUTICALS, LP |
00310-3200-05 |
ANDEXXA |
10 MG |
1 |
5 |
20 |
100 |
J7169 |
Inj andexxa, 10 mg |
ALEXION PHARMACEUTICALS |
69853-0102-01 |
Andexxa |
10 MG |
1 |
4 |
20 |
80 |
J7342 |
Inject, ciprofloxacin otic |
ALK-ABELLO INC. |
00268-8200-01 |
OTIPRIO |
6 MG |
1 |
1 |
10 |
10 |
J7352 |
Afamelanotide implant, 1 mg |
CLINUVEL |
73372-0116-01 |
Scenesse |
1 MG |
1 |
1 |
16 |
16 |
J7501 |
Azathioprine parenteral |
HIKMA PHARMACEUTICALS USA INC. |
00143-9566-01 |
AZATHIOPRINE INJECTION |
100 MG |
1 |
1 |
1 |
1 |
J9019 |
Erwinaze injection |
JAZZ PHARMACEUTICALS, INC. |
57902-0249-05 |
ERWINAZE |
1,000 IU |
1 |
5 |
10 |
50 |
J9029 |
Instill adstiladrin, tx dose |
Ferring Pharmaceuticals |
55566-1050-01 |
Adstiladrin |
PER THERAPEUTIC DOSE |
20 |
4 |
1 |
1 |
J9037 |
Inj belantamab mafodont blmf |
GLAXOSMITHKLINE |
00173-0896-01 |
Blenrep |
0.5 MG |
1 |
1 |
200 |
200 |
J9046 |
Inj, bortezomib, dr. reddy’s |
DR. REDDY'S LABORATORIES, INC. |
43598-0865-60 |
Bortezomib |
0.1 MG |
1 |
1 |
35 |
35 |
J9048 |
Inj, bortezomib freseniuskab |
FRESENIUS KABI |
63323-0721-10 |
Bortezomib |
0.1 MG |
1 |
1 |
35 |
35 |
J9057 |
Inj., copanlisib, 1 mg |
BAYER HEALTHCARE PHARMACEUTICALS INC. |
50419-0385-01 |
ALIQOPA |
1 MG |
1 |
1 |
60 |
60 |
J9072 |
Inj cyclophos dr.reddy's 5mg |
Dr. Reddy's Laboratories Inc. |
43598-0660-11 |
Cyclophosphamide (Dr. Reddy's) |
5 MG |
1 |
1 |
100 |
100 |
J9072 |
Inj cyclophos dr.reddy's 5mg |
Dr. Reddy's Laboratories Inc. |
43598-0661-11 |
Cyclophosphamide (Dr. Reddy's) |
5 MG |
2 |
1 |
200 |
200 |
J9072 |
Inj cyclophos dr.reddy's 5mg |
Dr. Reddy's Laboratories Inc. |
43598-0662-11 |
Cyclophosphamide (Dr. Reddy's) |
5 MG |
4 |
1 |
400 |
400 |
J9214 |
Interferon alfa-2b inj |
SCHERING CORPORATION |
00085-4350-01 |
Intron-A |
1 MIL UNITS |
1 |
1 |
10 |
10 |
J9214 |
Interferon alfa-2b inj |
SCHERING CORPORATION |
00085-4351-01 |
Intron-A |
1 MIL UNITS |
1 |
1 |
18 |
18 |
J9214 |
Interferon alfa-2b inj |
SCHERING CORPORATION |
00085-4352-01 |
Intron-A |
1 MIL UNITS |
1 |
1 |
50 |
50 |
J9225 |
Vantas implant |
ENDO PHARMACEUTICALS VALERA INC. |
67979-0500-01 |
Vantas implant |
50 MG |
1 |
1 |
1 |
1 |
J9247 |
Inj, melphalan flufenami 1mg |
ONCOPEPTIDES, INC. |
73657-0020-01 |
Pepaxto |
1 MG |
1 |
1 |
20 |
20 |
J9296 |
Inj pemetrexed (accord) 10mg |
Accord Healthcare Inc. |
16729-0522-05 |
Pemetrexed |
10 mg |
20 |
1 |
50 |
50 |
J9296 |
Inj pemetrexed (accord) 10mg |
ACCORD HEALTHCARE |
16729-0522-28 |
PEMETREXED |
10 MG |
34 |
1 |
85 |
85 |
J9296 |
Inj pemetrexed (accord) 10mg |
Accord Healthcare Inc. |
16729-0522-35 |
Pemetrexed |
10 mg |
40 |
1 |
100 |
100 |
J9296 |
Inj pemetrexed (accord) 10mg |
Accord Healthcare Inc. |
16729-0522-64 |
Pemetrexed |
10 mg |
4 |
1 |
10 |
10 |
J9302 |
Ofatumumab injection |
NOVARTIS PHARMACEUTICALS CORPORATION |
00078-0669-13 |
ARZERRA |
10 MG |
5 |
3 |
10 |
30 |
J9302 |
Ofatumumab injection |
NOVARTIS PHARMACEUTICALS CORPORATION |
00078-0690-61 |
ARZERRA |
10 MG |
50 |
1 |
100 |
100 |
J9314 |
Inj pemetrexed (teva) 10mg |
TEVA PHARMACEUTICALS USA, INC. |
00480-4514-01 |
Pemetrexed |
10 MG |
20 |
1 |
50 |
50 |
J9314 |
Inj pemetrexed (teva) 10mg |
TEVA PHARMACEUTICALS USA, INC. |
00480-4515-01 |
Pemetrexed |
10 MG |
40 |
1 |
100 |
100 |
J9314 |
Inj pemetrexed (teva) 10mg |
TEVA PHARMACEUTICALS USA, INC. |
00480-4516-01 |
Pemetrexed |
10 MG |
4 |
1 |
10 |
10 |
J9318 |
Inj romidepsin non-lyo 0.1mg |
SICOR PHARMACEUTICALS, INC. |
00703-4004-01 |
Romidepsin non-lyophilized |
0.1 MG |
5.5 |
1 |
275 |
275 |
J9320 |
Streptozocin injection |
SICOR PHARMACEUTICALS, INC. |
00703-4636-01 |
Zanosar |
1 GM |
1 |
1 |
1 |
1 |
J9333 |
Inj ronzanolixizum-noli 1 mg |
UCB |
50474-0980-79 |
Rystiggo |
1 MG |
2 |
1 |
280 |
280 |
J9334 |
Inj efgart-alfa 2mg hya-qvfc |
Argenx US |
73475-3102-03 |
Vyvgart Hytrulo |
2 MG |
5.6 |
1 |
504 |
504 |
J9371 |
Inj, Vincristine sul lip 1mg |
ACROTECH BIOPHARMA |
72893-0008-03 |
Vincristine Sulfate |
1 MG |
1 |
1 |
5 |
5 |
J9393 |
Inj, fulvestrant (teva) |
ACTAVIS PHARMA, INC. |
00591-5019-02 |
FULVESTRANT |
25 MG |
5 |
2 |
10 |
20 |
J9600 |
Porfimer sodium injection |
PINNACLE BIOLOGICS, INC. |
76128-0155-75 |
Photofrin |
75 MG |
1 |
1 |
1 |
1 |
Q2009 |
Fosphenytoin inj PE |
HIKMA PHARMACEUTICALS USA INC. |
00641-6136-25 |
FOSPHENYTOIN SODIUM |
50 MG PE/ML |
2 |
25 |
2 |
50 |
Q2009 |
Fosphenytoin inj PE |
FRESENIUS KABI |
63323-0403-02 |
FOSPHENYTOIN SODIUM |
50 MG PE/ML |
2 |
25 |
2 |
50 |
Q2009 |
Fosphenytoin inj PE |
FRESENIUS KABI |
63323-0403-10 |
FOSPHENYTOIN SODIUM |
50 MG PE/ML |
10 |
10 |
10 |
100 |
Q2009 |
Fosphenytoin inj PE |
PFIZER INC. |
00069-5471-02 |
CEREBYX |
50 MG PE/ML |
2 |
25 |
2 |
50 |
Q2009 |
Fosphenytoin inj PE |
PFIZER INC. |
00069-5474-02 |
CEREBYX |
50 MG PE/ML |
10 |
10 |
10 |
100 |
Q2009 |
Fosphenytoin inj PE |
PFIZER INC. |
00069-6001-21 |
CEREBYX |
50 MG PE/ML |
10 |
10 |
10 |
100 |
Q2009 |
Fosphenytoin inj PE |
PFIZER INC. |
00069-6001-25 |
CEREBYX |
50 MG PE/ML |
2 |
25 |
2 |
50 |
Q5120 |
Inj pegfilgrastim-bmez 0.5mg |
SANDOZ |
61314-0866-01 |
ZIEXTENZO |
0.5 MG |
0.6 |
1 |
12 |
12 |
Q9968 |
Visualization adjunct |
MYLAN INSTITUTIONAL LLC |
67457-0220-05 |
ISOSULFAN BLUE INJECTION |
1 MG |
5 |
6 |
50 |
300 |
Q9968 |
Visualization adjunct |
AMERICAN REGENT |
00517-0374-05 |
Provayblue |
1 MG |
10 |
5 |
50 |
250 |